James H Stanker - Net Worth and Insider Trading
James H Stanker Net Worth
The estimated net worth of James H Stanker is at least $3,469 dollars as of 2024-05-22. James H Stanker is the CFO of Processa Pharmaceuticals Inc and owns about 1,826 shares of Processa Pharmaceuticals Inc (PCSA) stock worth over $3,469. Details can be seen in James H Stanker's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that James H Stanker has not made any transactions after 2021-06-21 and currently still holds the listed stock(s).
Transaction Summary of James H Stanker
James H Stanker Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James H Stanker owns 2 companies in total, including Processa Pharmaceuticals Inc (PCSA) , and GSE Systems Inc (GVP) .
Click here to see the complete history of James H Stanker’s form 4 insider trades.
Insider Ownership Summary of James H Stanker
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PCSA | Processa Pharmaceuticals Inc | 2023-10-10 | Chief Financial Officer |
| GVP | GSE Systems Inc | 2016-08-08 | director |
James H Stanker Latest Holdings Summary
James H Stanker currently owns a total of 1 stock. James H Stanker owns 1,826 shares of Processa Pharmaceuticals Inc (PCSA) as of June 21, 2021, with a value of $3,469.
Latest Holdings of James H Stanker
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PCSA | Processa Pharmaceuticals Inc | 2021-06-21 | 1,826 | 1.90 | 3,469 |
Holding Weightings of James H Stanker
James H Stanker Form 4 Trading Tracker
According to the SEC Form 4 filings, James H Stanker has made a total of 3 transactions in Processa Pharmaceuticals Inc (PCSA) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Processa Pharmaceuticals Inc is the acquisition of 50 shares on June 21, 2021, which cost James H Stanker around $6,810.
Insider Trading History of James H Stanker
- 1
James H Stanker Trading Performance
GuruFocus tracks the stock performance after each of James H Stanker's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James H Stanker is 6.5%. GuruFocus also compares James H Stanker's trading performance to market benchmark return within the same time period. The performance of stocks bought by James H Stanker within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James H Stanker's insider trading performs compared to the benchmark.
Performance of James H Stanker
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -20.65 | | | | | |
| Relative Return to S&P 500(%) | -19.52 | | | | | |
James H Stanker Ownership Network
James H Stanker Owned Company Details
What does Processa Pharmaceuticals Inc do?
Who are the key executives at Processa Pharmaceuticals Inc?
James H Stanker is the Chief Financial Officer of Processa Pharmaceuticals Inc. Other key executives at Processa Pharmaceuticals Inc include director & 10 percent owner & President & CEO David Young , Chief Business - Strategy Off Patrick Lin , and Chief Executive Officer George K Ng .
Processa Pharmaceuticals Inc (PCSA) Insider Trades Summary
Over the past 18 months, James H Stanker made no insider transaction in Processa Pharmaceuticals Inc (PCSA). Other recent insider transactions involving Processa Pharmaceuticals Inc (PCSA) include a net purchase of 161,000 shares made by David Young , a net purchase of 10,000 shares made by George K Ng , and a net purchase of 8,000 shares made by Justin W Yorke .
In summary, during the past 3 months, insiders sold 0 shares of Processa Pharmaceuticals Inc (PCSA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Processa Pharmaceuticals Inc (PCSA) were sold and 69,000 shares were bought by its insiders, resulting in a net purchase of 69,000 shares.
Processa Pharmaceuticals Inc (PCSA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Processa Pharmaceuticals Inc Insider Transactions
James H Stanker Mailing Address
Above is the net worth, insider trading, and ownership report for James H Stanker. You might contact James H Stanker via mailing address: 9008 Shadybrook Drive, Frederick Md 21701.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
